STIM MEXC RealStocks
Own real STIM shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 19:22:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Neuronetics, Inc. (STIM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.46, with a market capitalization of $156.23M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.80 to $3.44. This page covers its latest market performance, valuation, price trends and company information.
$156.23M | |
$1.60 | |
$1.64 | |
$1.39 | |
$1.62 | |
4.94M | |
1.33M | |
-- | |
$3.44 | |
$0.80 | |
-- | |
-- |
Neuronetics, Inc. (STIM) is currently trading at $1.46 as of 2026-11-12 19:21:00, down 10.19% ($0.17) from the previous close of $1.62
During today's regular trading session, STIM has traded between $1.39 and $1.64, with a trading volume of 4.94M shares. The current price is near the lower end of today's range.
Over the past seven days, Neuronetics, Inc. (STIM) moved from $2.26 to $1.46, representing a decline of 35.62% ($0.80).
The stock traded between $1.39 and $3.05 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.87 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 24.8%
STIM is currently trading at $1.46, placing it 24.8% of the way from its 52-week low of $0.80 to its 52-week high of $3.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 658 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Neuronetics, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Neuronetics, Inc. (STIM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to STIM, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between STIM shares and USD.
STIM Shares to USD
1.00 STIM shares = 1.455 USD
Calculations are estimates based on the latest available price and are for reference only.